Diflucan

Diflucan is a brand name of fluconazole, approved by the FDA in the following formulation(s):

DIFLUCAN (fluconazole - for suspension; oral)

• 
  Manufacturer: PFIZER
  
  Approval date: December 23, 1993
  
  Strength(s): 200MG/5ML ^[RLD][AB], 50MG/5ML ^[AB]

DIFLUCAN (fluconazole - tablet; oral)

• 
  Manufacturer: PFIZER
  
  Approval date: January 29, 1990
  
  Strength(s): 100MG ^[AB], 200MG ^[RLD][AB], 50MG ^[AB]


• 
  Manufacturer: PFIZER
  
  Approval date: June 30, 1994
  
  Strength(s): 150MG ^[AB]

Has a generic version of Diflucan been approved?

Yes. The following products are equivalent to Diflucan:

fluconazole for suspension; oral

• 
  Manufacturer: AUROBINDO PHARM
  
  Approval date: September 18, 2009
  
  Strength(s): 200MG/5ML ^[AB], 50MG/5ML ^[AB]


• 
  Manufacturer: IVAX SUB TEVA PHARMS
  
  Approval date: September 12, 2007
  
  Strength(s): 200MG/5ML ^[AB], 50MG/5ML ^[AB]


• 
  Manufacturer: RANBAXY
  
  Approval date: July 29, 2004
  
  Strength(s): 200MG/5ML ^[AB], 50MG/5ML ^[AB]


• 
  Manufacturer: ROXANE
  
  Approval date: July 29, 2004
  
  Strength(s): 200MG/5ML ^[AB], 50MG/5ML ^[AB]


• 
  Manufacturer: TARO PHARM INDS
  
  Approval date: December 18, 2006
  
  Strength(s): 200MG/5ML ^[AB], 50MG/5ML ^[AB]

fluconazole tablet; oral

• 
  Manufacturer: AMNEAL PHARM
  
  Approval date: March 7, 2011
  
  Strength(s): 100MG ^[AB], 150MG ^[AB], 200MG ^[AB], 50MG ^[AB]


• 
  Manufacturer: APOTEX
  
  Approval date: July 29, 2004
  
  Strength(s): 100MG ^[AB], 150MG ^[AB], 200MG ^[AB], 50MG ^[AB]


• 
  Manufacturer: AUROBINDO PHARMA
  
  Approval date: October 7, 2008
  
  Strength(s): 100MG ^[AB], 150MG ^[AB], 200MG ^[AB], 50MG ^[AB]


• 
  Manufacturer: GLENMARK GENERICS
  
  Approval date: January 25, 2006
  
  Strength(s): 100MG ^[AB], 150MG ^[AB], 200MG ^[AB], 50MG ^[AB]


• 
  Manufacturer: IVAX SUB TEVA PHARMS
  
  Approval date: July 29, 2004
  
  Strength(s): 100MG ^[AB], 150MG ^[AB], 200MG ^[AB], 50MG ^[AB]


• 
  Manufacturer: MYLAN
  
  Approval date: July 29, 2004
  
  Strength(s): 100MG ^[AB], 100MG ^[AB], 150MG ^[AB], 150MG ^[AB], 200MG ^[AB], 200MG ^[AB], 50MG ^[AB], 50MG ^[AB]


• 
  Manufacturer: RANBAXY
  
  Approval date: July 29, 2004
  
  Strength(s): 100MG ^[AB], 150MG ^[AB], 200MG ^[AB], 50MG ^[AB]


• 
  Manufacturer: TARO
  
  Approval date: July 29, 2004
  
  Strength(s): 100MG ^[AB], 150MG ^[AB], 200MG ^[AB], 50MG ^[AB]


• 
  Manufacturer: TEVA
  
  Approval date: July 29, 2004
  
  Strength(s): 100MG ^[AB], 150MG ^[AB], 200MG ^[AB], 50MG ^[AB]


• 
  Manufacturer: UNIQUE PHARM LABS
  
  Approval date: September 28, 2005
  
  Strength(s): 100MG ^[AB], 200MG ^[AB], 50MG ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Diflucan. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Diflucan.

See also...

• Diflucan Consumer Information (Drugs.com)
• Diflucan Consumer Information (Wolters Kluwer)
• Diflucan Single-Dose Tablets Consumer Information (Wolters Kluwer)
• Diflucan Solution Consumer Information (Wolters Kluwer)
• Diflucan Suspension Consumer Information (Wolters Kluwer)
• Diflucan Consumer Information (Cerner Multum)
• Diflucan Advanced Consumer Information (Micromedex)
• Diflucan IV Advanced Consumer Information (Micromedex)
• Diflucan Intravenous Advanced Consumer Information (Micromedex)
• Diflucan AHFS DI Monographs (ASHP)
• Fluconazole Consumer Information (Wolters Kluwer)
• Fluconazole Single-Dose Tablets Consumer Information (Wolters Kluwer)
• Fluconazole Solution Consumer Information (Wolters Kluwer)
• Fluconazole Suspension Consumer Information (Wolters Kluwer)
• Fluconazole Consumer Information (Cerner Multum)
• CanesOral Advanced Consumer Information (Micromedex)
• Fluconazole Advanced Consumer Information (Micromedex)
• Fluconazole Intravenous Advanced Consumer Information (Micromedex)
• Fluconazole AHFS DI Monographs (ASHP)

Teicoplanina Northia

Teicoplanina Northia may be available in the countries listed below.

Ingredient matches for Teicoplanina Northia

Teicoplanin

Teicoplanin is reported as an ingredient of Teicoplanina Northia in the following countries:

• Argentina

International Drug Name Search

Céfotaxime G Gam

Céfotaxime G Gam may be available in the countries listed below.

Ingredient matches for Céfotaxime G Gam

Cefotaxime

Cefotaxime sodium salt (a derivative of Cefotaxime) is reported as an ingredient of Céfotaxime G Gam in the following countries:

• France

International Drug Name Search

Novolizer Formoterol

Novolizer Formoterol may be available in the countries listed below.

Ingredient matches for Novolizer Formoterol

Formoterol

Formoterol fumarate dihydrate (a derivative of Formoterol) is reported as an ingredient of Novolizer Formoterol in the following countries:

• Austria


• Belgium


• Luxembourg

International Drug Name Search

Xolegel

Xolegel is a brand name of ketoconazole topical, approved by the FDA in the following formulation(s):

XOLEGEL (ketoconazole - gel; topical)

• 
  Manufacturer: AQUA PHARMS
  
  Approval date: July 28, 2006
  
  Strength(s): 2% ^[RLD]

Has a generic version of Xolegel been approved?

No. There is currently no therapeutically equivalent version of Xolegel available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Xolegel. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Anhydrous topical skin preparations
  Patent 7,179,475
  Issued: February 20, 2007
  Inventor(s): Burnett; Katherine M. & Kurtz; Ellen S.
  Assignee(s): Johnson & Johnson Consumer Companies, Inc.
  The present invention provides anhydrous compositions for topical delivery of a medicament comprising (A) a penetration enhancer/solvent selected from the group consisting of alcohol, propylene glycol, or a combination thereof; (B) a humectant/solvent selected from the group consisting of polyethylene glycol, glycerin, sorbitol, xylitol, or any combination of any of the foregoing; and (C) an anhydrous vehicle. In an alternate embodiment, the present invention provides anhydrous compositions for topical delivery of a medicament which comprise (A) a penetration enhancer/solvent selected from the group consisting of alcohol, propylene glycol, or a combination thereof; (B) a humectant/solvent selected from the group consisting of polyethylene glycol, glycerin, sorbitol, xylitol or any combination of any of the foregoing; (C) an anhydrous vehicle; and (D) a medicament. Also provided are methods for topically delivering a medicament to an animal, such as a mammal or a human patient, in need of the medicament by topically administering to the animal the compositions of the present invention.
  
  Patent expiration dates:
  
  
  • December 4, 2018
    
    ✓ 
    Patent use: TREATMENT OF SEBORRHEA DERMATITIS IN HUMANS
    ✓ 
    Drug product
  
  

See also...

• Xolegel Consumer Information (Drugs.com)
• Xolegel Gel Consumer Information (Wolters Kluwer)
• Xolegel Consumer Information (Cerner Multum)
• Xolegel Topical Advanced Consumer Information (Micromedex)
• Ketoconazole Cream Consumer Information (Wolters Kluwer)
• Ketoconazole Foam Consumer Information (Wolters Kluwer)
• Ketoconazole Gel Consumer Information (Wolters Kluwer)
• Ketoconazole Shampoo Consumer Information (Wolters Kluwer)
• Ketoconazole topical Consumer Information (Cerner Multum)
• Ketoderm Topical Advanced Consumer Information (Micromedex)
• Ketoconazole Topical Advanced Consumer Information (Micromedex)
• Ketoconazole topical AHFS DI Monographs (ASHP)

Monedax

Monedax may be available in the countries listed below.

Ingredient matches for Monedax

Epalrestat

Epalrestat is reported as an ingredient of Monedax in the following countries:

• Japan

International Drug Name Search

VisionBlue

VisionBlue is a brand name of trypan blue ophthalmic, approved by the FDA in the following formulation(s):

VISIONBLUE (trypan blue - solution; ophthalmic)

• 
  Manufacturer: DORC
  
  Approval date: December 16, 2004
  
  Strength(s): 0.06% ^[RLD]

Has a generic version of VisionBlue been approved?

No. There is currently no therapeutically equivalent version of VisionBlue available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of VisionBlue. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with VisionBlue.

See also...

• VisionBlue Advanced Consumer Information (Micromedex)
• Vision Blue Consumer Information (Drugs.com)
• Trypan blue Intraocular Advanced Consumer Information (Micromedex)

Elocon

Elocon is a brand name of mometasone topical, approved by the FDA in the following formulation(s):

ELOCON (mometasone furoate - cream; topical)

• 
  Manufacturer: SCHERING
  
  Approval date: May 6, 1987
  
  Strength(s): 0.1% ^[RLD][AB]

ELOCON (mometasone furoate - lotion; topical)

• 
  Manufacturer: SCHERING
  
  Approval date: March 30, 1989
  
  Strength(s): 0.1% ^[RLD][AB]

ELOCON (mometasone furoate - ointment; topical)

• 
  Manufacturer: SCHERING
  
  Approval date: April 30, 1987
  
  Strength(s): 0.1% ^[RLD][AB]

Has a generic version of Elocon been approved?

Yes. The following products are equivalent to Elocon:

mometasone furoate cream; topical

• 
  Manufacturer: FOUGERA PHARMS
  
  Approval date: April 8, 2005
  
  Strength(s): 0.1% ^[AB]


• 
  Manufacturer: G AND W LABS
  
  Approval date: May 22, 2006
  
  Strength(s): 0.1% ^[AB]


• 
  Manufacturer: GLENMARK GENERICS
  
  Approval date: May 28, 2008
  
  Strength(s): 0.1% ^[AB]


• 
  Manufacturer: TARO
  
  Approval date: December 21, 2004
  
  Strength(s): 0.1% ^[AB]


• 
  Manufacturer: TOLMAR
  
  Approval date: April 18, 2007
  
  Strength(s): 0.1% ^[AB]

mometasone furoate lotion; topical

• 
  Manufacturer: FOUGERA PHARMS
  
  Approval date: November 29, 2007
  
  Strength(s): 0.1% ^[AB]


• 
  Manufacturer: G AND W LABS
  
  Approval date: November 21, 2007
  
  Strength(s): 0.1% ^[AB]


• 
  Manufacturer: GLENMARK GENERICS
  
  Approval date: August 9, 2010
  
  Strength(s): 0.1% ^[AB]


• 
  Manufacturer: PERRIGO
  
  Approval date: April 6, 2005
  
  Strength(s): 0.1% ^[AB]


• 
  Manufacturer: TARO
  
  Approval date: March 15, 2006
  
  Strength(s): 0.1% ^[AB]


• 
  Manufacturer: TOLMAR
  
  Approval date: November 21, 2007
  
  Strength(s): 0.1% ^[AB]

mometasone furoate ointment; topical

• 
  Manufacturer: FOUGERA PHARMS
  
  Approval date: March 28, 2005
  
  Strength(s): 0.1% ^[AB]


• 
  Manufacturer: G AND W LABS
  
  Approval date: June 20, 2006
  
  Strength(s): 0.1% ^[AB]


• 
  Manufacturer: GLENMARK GENERICS
  
  Approval date: May 28, 2008
  
  Strength(s): 0.1% ^[AB]


• 
  Manufacturer: PERRIGO NEW YORK
  
  Approval date: March 18, 2002
  
  Strength(s): 0.1% ^[AB]


• 
  Manufacturer: TARO
  
  Approval date: December 3, 2004
  
  Strength(s): 0.1% ^[AB]


• 
  Manufacturer: TOLMAR
  
  Approval date: November 14, 2003
  
  Strength(s): 0.1% ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Elocon. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Elocon.

See also...

• Elocon Consumer Information (Drugs.com)
• Elocon Cream Consumer Information (Wolters Kluwer)
• Elocon Lotion Consumer Information (Wolters Kluwer)
• Elocon Consumer Information (Cerner Multum)
• Elocon Advanced Consumer Information (Micromedex)
• Elocon topical AHFS DI Monographs (ASHP)
• Mometasone Cream Consumer Information (Wolters Kluwer)
• Mometasone Lotion Consumer Information (Wolters Kluwer)
• Mometasone topical Consumer Information (Cerner Multum)
• Elocom Advanced Consumer Information (Micromedex)
• Pms-Mometasone Advanced Consumer Information (Micromedex)
• Mometasone Topical application Advanced Consumer Information (Micromedex)
• Mometasone Furoate topical AHFS DI Monographs (ASHP)